PSRX.TA TLV
PsyRX CNS Bio-Tech Ltd
1W: +1.0%
1M: -8.0%
3M: -22.8%
YTD: -43.4%
₪70.00 ($0.23)
+0.40 (+0.57%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap₪0.3M ($0.0M)
52W Range0.8-219.5
Volume1,466
Avg Volume8,811
Beta0.47
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOItay Hecht
Employees6
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2025-11-27
Websitepsyrx.co
34 Yitzhak Sadeh
Tel Aviv-Jaffa, TA 6721207
IL
Tel Aviv-Jaffa, TA 6721207
IL
972 5 44988960
About PsyRX CNS Bio-Tech Ltd
PsyRX CNS Bio-Tech Ltd is dedicated to developing cannabinoid-based pharmaceuticals and healthcare products. Its portfolio encompasses drugs targeting diverse medical conditions, personalized cannabinoid formulations, and CBD-infused skincare along with food supplements. Established in 2019, the company, formerly known as Cannabotech LTD, is headquartered in Rishon LeZion, Israel.
Latest News
No recent news
Recent Insider Trades
No insider trades found